These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 401736)
1. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly]. Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736 [No Abstract] [Full Text] [Related]
2. The growth hormone responses to L-dopa and TRH in acromegaly. Jialal I; Naidoo C; Nathoo BC; Rajput MC; Joubert SM J Endocrinol Invest; 1984 Jun; 7(3):235-7. PubMed ID: 6432894 [TBL] [Abstract][Full Text] [Related]
3. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly. Maeda K Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578 [No Abstract] [Full Text] [Related]
4. [Abnormal reaction of GH to TRH and l-dopa stimulation in acromegaly]. Haniu K; Taya T; Aida M; Yoshinaga K Horumon To Rinsho; 1976 Nov; 24(11):1145-50. PubMed ID: 827402 [No Abstract] [Full Text] [Related]
5. [Acromegaly. Physiopathological aspects and description of a clinical case]. Coppola A; Spera C; Buono V; Esposito C; Nasti A Minerva Med; 1986 Mar; 77(11):395-401. PubMed ID: 3085021 [TBL] [Abstract][Full Text] [Related]
6. Plasma growth hormone and prolactin response to thyrotropin releasing hormone, L-dopa and luteinizing hormone-releasing hormone in alcoholic patients with liver cirrhosis. Zanoboni A; Zanoboni-Muciaccia W; Bonfanti M; Gattei G; Zecca L Farmaco Prat; 1980 Sep; 35(9):455-65. PubMed ID: 6778710 [No Abstract] [Full Text] [Related]
7. [Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly]. Candrina R Medicina (Firenze); 1988; 8(2):180-1. PubMed ID: 3147351 [No Abstract] [Full Text] [Related]
8. [Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment]. Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA Clin Ter; 1977 Aug; 82(3):203-12. PubMed ID: 410583 [No Abstract] [Full Text] [Related]
9. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type]. Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351 [No Abstract] [Full Text] [Related]
10. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa. Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963 [TBL] [Abstract][Full Text] [Related]
11. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. Alster DK; Bowers CY; Jaffe CA; Ho PJ; Barkan AL J Clin Endocrinol Metab; 1993 Sep; 77(3):842-5. PubMed ID: 8370708 [TBL] [Abstract][Full Text] [Related]
12. Secretion of growth hormone after L-dopa stimulation in patients with renal failure treated with dialyses. Kuska J; Kokot F; Sledziński Z Acta Med Pol; 1979; 20(3):217-26. PubMed ID: 517160 [No Abstract] [Full Text] [Related]
13. [Effect of changes in hypothalamic neurotransmitters on the release of growth hormone by thyrotropin-releasing hormone in chronic renal insufficiency on hemodialysis]. Barba A; Mangas-Rojas A; García JF; Zamora-Madaria E Rev Clin Esp; 1988 Mar; 182(4):196-9. PubMed ID: 3137645 [No Abstract] [Full Text] [Related]
14. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients. Dobrew D; Zonew I; Milanow S Ther Hung; 1977; 25(4):145-9. PubMed ID: 605413 [No Abstract] [Full Text] [Related]
17. [Response of growth hormone to the acute test using GH-releasing factor 1-29 in acromegaly. Comparison in the baseline situation and under treatment with prolonged-action somatostatin]. Gavilán I; Santos C; García-Luna PP; Acosta D; Leal-Cerro A; Navarro E; Fernández-López I; Astorga R Rev Clin Esp; 1988 Mar; 182(4):187-91. PubMed ID: 2901136 [No Abstract] [Full Text] [Related]
18. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly]. Fossati P; Asfour M; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Brion-Brevan B Lille Med; 1976 Nov; 19(9):757-65. PubMed ID: 1004102 [No Abstract] [Full Text] [Related]
19. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs. Richards GE; Holland FJ; Aubert ML; Ganong WF; Kaplan SL; Grumbach MM Neuroendocrinology; 1980; 30(3):139-43. PubMed ID: 6767993 [TBL] [Abstract][Full Text] [Related]
20. Bromoergocriptine and growth hormone (GH) dynamics in health and hypersomatotropism. Sachdev Y J Assoc Physicians India; 1983 Apr; 31(4):195-9. PubMed ID: 6417104 [No Abstract] [Full Text] [Related] [Next] [New Search]